Appendix  A

Appendix B

Appendix C

Appendix D1

Appendix D2

Appendix D3


Posted as supplied by authors

Appendix A

Search step

Explanation

Patient inclusion criteria


  1. exp Hypertension/

Exploded MESH heading ‘Hypertension’

  • (hypertension or hypertensiv$).ti.
  • Words in title: ‘hypertension’ or truncated ‘hypertensiv’

  • hypertension.ab. /freq=2 or hypertensiv$.ab. /freq=2
  • Words in abstract at least twice: ‘hypertension’ or truncated ‘hypertensiv’

  • or/1-3 Hypertension
  • 1 OR 2 OR 3

    intervention Inclusion criteria


  • exp Blood Pressure Monitoring, Ambulatory/ or exp Blood Pressure Determination/ or exp Blood Pressure Monitors/
  • Exploded MESH heading ‘Blood Pressure Monitoring, Ambulatory’ or ‘Blood Pressure Monitors’ or ‘Blood Pressure Determination’

  • (blood adj pressure adj5 (measur$ or monitor$)).tw.
  • ‘blood pressure’ within five words of truncated ‘measur’ or truncated ‘monitor’ in title or abstract

  • or/5-6 Blood pressure measurement
  • 4 OR 5 OR 6

  • (home or self$).tw.
  • ‘home’ or truncated ‘self’ in title or abstract

  • exp Telemedicine/
  • Exploded MESH heading ‘Telemedicine’

  • (telemedic$ or telemonitor$).tw.
  • truncated ‘telemedic’ or truncated ‘telemonitor’ in title or abstract

  • or/8-10 home monitoring
  • 8 OR 9 OR 10

  • 7 and 11
  • Blood pressure measurement AND home monitoring

    13. 4 and 12

    Blood pressure measurement AND home monitoring AND Hypertension

    study desigN Inclusion criteria


    14. (random$ or placebo$)

    truncated ‘random’ or truncated ‘placebo in title or abstract or subject heading or publication type

    15. ((double$ or single$ or triple$ or treble$) and (blind$ or mask$))

    (truncated ‘double’ or truncated ‘single’ or truncated ‘triple’ or truncated ‘treble’) in combination with (truncated ‘blind’ or truncated ‘mask’)

    16. (clinical trial or controlled clinical trial).pt

    publication type clinical trial or controlled clinical trial

    17. exp randomized controlled trials/ or randomized controlled trials.tw,sh. (27378)

    Exploded MeSH heading Randomized Controlled Trials or randomized controlled trials as a textword or subject heading

    18. Randomized controlled trial.pt

    publication type randomised controlled trial

    19. or/25-29 RCTs

    14 or 15 or 16 or 17 or 18

    COMBINING patient group, intervention and STUDY DESIGN


    20. 13 and 29

    Blood pressure measurement AND home monitoring AND Hypertension AND RCTs



    Appendix B: Methods of assessment of outcome

    Date

    First author

    Blind outcome assessment

    Who took outcome blood pressure

    Automatic machine

    Method of taking outcome blood pressure

    1975

    Carnahan

    Yes

    clinic nurses

    not stated

    Not stated

    1976

    Haynes

    Yes

    researcher

    not stated

    "standardised method"

    1978

    Johnson

    Yes

    researcher

    not stated

    Average of 2nd and 3rd readings 5 minutes apart

    1982

    Earp

    not stated

    clinic staff

    not stated

    ‘Average' blood pressure at 'routine clinic visit'

    1984

    Pierce

    Yes

    clinic staff

    not stated

    medical records

    1984

    Stahl

    No

    clinic nurse

    No

    Average of previous 6 months readings

    1988

    Binstock

    not stated

    clinic nurse

    not stated

    Not stated

    1991

    Midanik

    not stated

    researcher

    not stated

    Not stated

    1992

    Soghikian

    No

    researcher

    No

    Second of two resting measurements, 1 minute apart

    1993

    Muhlhauser

    not stated

    clinic staff

    not stated

    Mean of last two BPs in medical records

    1996

    Friedman

    Yes

    researcher

    not stated

    Average of 2 readings 5 minutes apart

    1997

    Zarnke

    Yes

    researcher

    Yes

    24 hr ambulatory BP

    1999

    Bailey

    not stated

    research nurse

    not stated

    Sitting

    2000

    Mehos

    Not stated

    researcher

    No

    Average of 2 readings

    2000

    Vetter

    Not stated

    clinic physician

    No

    BP measured in morning before medication, after 5 mins rest. Mean of three sitting measurements.

    2001

    Artinian

    Yes

    researcher

    Yes

    After 5 mins rest, mean of 2 readings

    2001

    Broege

    not stated

    researcher

    Yes

    Average daytime ambulatory BP

    2001

    Rogers

    Yes

    research nurse

    Yes

    24 hr ambulatory BP

     


    Appendix C. Blood pressure above target at follow-up

    author

    Number of patients

    Percentage above target

    Relative risk

    Definition

     

    I

    C

    I

    C

    (95% CI)

     

    Haynes,1976

    20

    18

    70

    89

    0.79 (0.57 to 1.10)

    dbp>=90

    Earp,1982 (1 year)

    74

    41

    39

    34

    1.15 ( 0.69 to 1.91)

    dbp>=95

    Earp,1982 (2 year)

    55

    34

    25

    21

    1.24 ( 0.56 to 2.75)

    dbp>=95

    Stahl,1984 (1 year)

    125

    149

    29

    36

    0.79 ( 0.56 to 1.13)

    not defined

    Stahl,1984 (2 year)

    108

    116

    33

    28

    1.17 ( 0.79 to 1.74

    not defined

    Mulhauser,1993

    86

    74

    85

    86

    0.98 (0.86 to 1.11)

    dbp>90 or sbp>140

    Mehos,2000

    18

    18

    56

    78

    0.71 ( 0.44 to 1.16)

    dbp>90 or sbp>140

    Vetter,2000

    296

    326

    34

    40

    0.84 (0.68 to 1.03)

    dbp>90

     

     

    Appendix D1. Systolic blood pressure. Mean and standard deviation of baseline, follow up and fall from baseline for intervention and control groups.

    Author

    Number of subjects

    Baseline sbp

    Follow up sbp

    Fall from baseline

    Intervention effect

     

    I

    C

    I

    C

    I

    C

    I

    C

    (95% CI)

    Carnaham,1975

    49

    48

    153

    157

    135

    146

    18.0 (16.5)b

    10.5 (16.5) b

    7.5 (0.9 to 14.1)

    Haynes,1976

    20

    18

    NR

    NR

    NR

    NR

    NC

    NC

     

    Johnson,1978

    69

    67

    NR

    NR

    NR

    NR

    NC

    NC

     

    Earp,1982

    74

    41

    NR

    NR

    NR

    NR

    NC

    NC

     

    Earp,1982

    55

    34

    NR

    NR

    NR

    NR

    NC

    NC

     

    Pierce,1984

    55

    58

    183 (23)

    180 (24)

    NR

    NR

    32.1 (22.3)

    33.3 (20.1)

    -1.2 (-9.0 to 6.6)

    Stah,1984 (1 year followup)

    125

    149

    168

    167

    NR

    NR

    NC

    NC

     

    Stahl,1984 (2 year follow up)

    108

    116

    168

    167

    NR

    NR

    NC

    NC

     

    Binstock,1988

    23

    32

    156

    151

    135

    148

    21.0 (16.5) b

    3.0 (16.5) b

    18.0 (9.2 to 26.8)

    Midanik,1991

    74

    72

    144 (16)

    144 (17)

    143 (16)

    145 (18)

    1.6 (14.5)

    -0.8 (14.2)

    2.4 (-2.3 to 7.1)

    Soghikann,1992

    200

    190

    137 (17)

    140 (18)

    136 (20)

    142 (17)

    1.4 (17.9)

    -1.8 (16.5)

    3.2 (-0.2 to 6.6)

    Mulhauser,1993

    86

    74

    162 (14)

    161(13)

    154(16)

    158 (18)

    8.0 (17.0)

    3.0 (18.0)

    5.0 (-0.5 to 10.5)

    Friedman,1996

    133

    134

    170

    167

    NR

    NR

    11.0 (16.5) b

    10.6 (16.5) b

    0.4 ( -3.6 to 4.4)

    Zarnke,1997

    20

    11

    NR

    NR

    NR

    NR

    NC

    NC

     

    Bailey,1999

    31

    29

    156 (22)

    155 (22)

    148 (17)

    142 (16)

    8.0 (19.5) a

    13.0 (19.2)a

    -5.0 (-14.8 to 4.8)

    Mehos,2000

    18

    18

    158 (16)

    154 (15)

    NR

    NR

    17.1 (14.0)

    7.0 (18.5)

    10.1 (-0.6 to 20.8)

    Vetter,2000

    296

    326

    166 (14)

    168 (14)

    145 (16)

    148 (15)

    21.0 (15.1) a

    20.5 (14.2) a

    0.5 ( -1.8 to 2.8)

    Artinian,2001

    6

    9

    149 (14)

    142 (17)

    124 (14)

    143 (11)

    24.7 (13.8) a

    -0.9 (13.6) a

    25.6 ( 11.4 to 39.8)

    Broege,2001

    20

    18

    150 (22)

    144 (20)

    146 (11)

    144 (19)

    4.0 (16.5) a

    0.0 (19.5) a

    4.0( -7.6 to 15.6)

    Rogers,2001

    60

    61

           

    4.9 (13.0)

    0.1 (13.2)

    4.8 (0.1 to 9.5)

    Where no standard deviation given for baseline and follow up it was not reported. NR – mean not reported aStandard deviation estimated as average

    of baseline and follow up sd. NC – mean difference either not reported or not calculable. b Standard deviation estimated as average sd.

     

    Appendix D2. Diastolic blood pressure. Mean and standard deviation of baseline, follow up and fall from baseline for intervention and control groups.

    Author

    Number of subjects

    Baseline dbp

    Follow up dbp

    Fall from baseline

    Intervention effect

     

    I

    C

    I

    C

    I

    C

    I

    C

    (95% CI)

    Carnaham,1975

    49

    48

    102

    104

    91

    93

    10.4 (9.3)b

    10.4 (9.3) b

    0.0 ( -3.7 to 3.7)

    Haynes,1976

    20

    18

    99 (6)

    98 (6)

    93 (6)

    96 (6)

    5.4 (7.2)

    1.9 (8.5)

    3.5 (-1.5 to 8.5)

    Johnson,1978

    69

    67

    103 (7)

    104 (9)

    95 (9)

    96 (11)

    8.5 (9.7)

    8.1 (10.0)

    0.4 ( -2.9 to 3.7)

    Earp,1982

    74

    41

    NR

    NR

    NR

    NR

    NC

    NC

     

    Earp,1982

    55

    34

    NR

    NR

    NR

    NR

    NC

    NC

     

    Pierce,1984

    55

    58

    107 (8)

    104 (9)

    NR

    NR

    19.1 (10.7)

    17.8 (9.1)

    1.3 ( -2.4 to 5.0)

    Stah,1984 (1 year)

    125

    149

    110

    109

    90

    92

    20.1 (9.3) b

    17.0 (9.3) b

    3.1 ( 0.9 to 5.3)

    Stahl,1984 (2 year)

    108

    116

    110

    109

    91

    90

    19.9 (9.3) b

    19.0 (9.3) b

    0.9 ( -1.5 to 3.3)

    Binstock,1988

    23

    32

    93

    90

    82

    89

    11.0 (9.3) b

    1.0 (9.3) b

    10.0 ( 5.0 to 15.0)

    Midanik,1991

    74

    72

    91 (9)

    93 (8)

    92 (10)

    94 (9)

    -1.0 (10.0)

    -0.9 (8.0)

    -0.1 ( -3.0 to 2.8)

    Soghikann,1992

    200

    190

    86 (8)

    86 (11)

    86 (10)

    88 (10)

    -0.1 (9.6)

    -1.7 (9.6)

    1.6 ( -0.3 to 3.5)

    Mulhauser,1993

    86

    74

    100 (7)

    98 (7)

    95 (9)

    96 (11)

    6.0 (11.0)

    2.0 (10.0)

    4.0 ( 0.7 to 7.3)

    Friedman,1996

    133

    134

    86

    84

    NR

    NR

    5.4 (9.3) b

    3.3 (9.3) b

    2.1 ( -0.1 to 4.3)

    Zarnke,1997

    20

    11

    9.3

    9.3

    NR

    NR

    NC

    NC

     

    Bailey,1999

    31

    29

    93 (11)

    95 (11)

    89 (11)

    89 (11)

    4.0 (11.1)a

    6.0 (10.8)a

    -2.0 ( -7.5 to 3.5)

    Mehos,2000

    18

    18

    91 (11)

    90 (10)

    NR

    NR

    10.5 (7.6)

    3.8 (8.9)

    6.7 ( 1.3 to 12.1)

    Vetter,2000

    296

    326

    102 (6)

    102 (6)

    89 (8)

    90 (8)

    13.2 (7.2) a

    11.9 (6.9) a

    1.3 (0.2 to 2.4)

    Artinian,2001

    6

    9

    90 (6)

    91 (9)

    76 (11)

    89 (11)

    14.6 (8.6) a

    2.1 (9.7) a

    12.5 ( 3.2 to 21.8)

    Broege,2001

    20

    18

    81 (12)

    82 (13)

    80 (8)

    83 (12)

    1.0 (10.0) a

    -1.0 (12.5) a

    2.0 ( -5.2 to 9.2)

    Rogers,2001

    60

    61

    NR

    NR

    NR

    NR

    2.0 (8.3)

    -2.1 (9.1)

    4.1 (1.0 to 7.2)

    Where no standard deviation given for baseline and follow up it was not reported. NR – mean not reported aStandard deviation estimated as average

    of baseline and follow up sd. NC – mean difference either not reported or not calculable. b Standard deviation estimated as average sd.

     

     

    Appendix D3. Mean arterial pressure . Mean and standard deviation of baseline, follow-up and fall from baseline for intervention and control groups. Only studies reporting this outcome are included

    Author

    Number of subjects

    Baseline map

    Follow up map

    Fall from baseline

    Intervention effect

     

    I

    C

    I

    C

    I

    C

    I

    C

    (95% CI)

    Zarnke,1997

    20

    11

    96 (9)

    100 (6)

    NR

    NR

    0.9 (5.8)

    -1.9 (4.6)

    2.9 ( -0.9 to 6.6)

    Mehos,2000

    18

    18

    113 (8)

    111 (6)

    NR

    NR

    12.7 (5.9)

    4.9 (9.8)

    7.8 (2.5 to 13.1)

    Rogers,2001

    60

    61

    NR

    NR

    NR

    NR

    2.8 (8.9)

    -1.3 (9.3)

    4.1 (0.9 to 7.3)

    NR – mean not reported

     


     



    Access all current jobs at BMJ Group
    Whats new online at Student 

BMJ
    Listen to the latest 

BMJ Interview